Andersen disease is one of those glycogen storage diseases that can feel “small” on Step 1—until a vignette shows a baby with progressive liver failure and an oddly fibrotic cirrhotic liver. This post will make Andersen (GSD IV) easy to recognize fast: what’s broken, why it causes cirrhosis, how it presents, and what you’re expected to do with it on test day.
Where Andersen Disease Fits (Big Picture)
Andersen disease is Glycogen Storage Disease type IV (GSD IV)—a glycogen branching enzyme defect.
Core idea: If you can’t branch glycogen properly, you accumulate abnormally structured glycogen that is poorly soluble and toxic to cells, especially in the liver → inflammation → progressive cirrhosis → liver failure.
Quick classification (Step-relevant)
| Category | Disease | Key defect | Classic organ |
|---|---|---|---|
| Glycogen storage | Andersen (IV) | Branching enzyme (GBE1) | Liver (cirrhosis) |
| Glycogen storage | Von Gierke (I) | Glucose-6-phosphatase | Liver/kidney (severe hypoglycemia) |
| Glycogen storage | Pompe (II) | Acid α-glucosidase (lysosomal) | Heart (cardiomegaly) |
| Glycogen storage | McArdle (V) | Muscle glycogen phosphorylase | Skeletal muscle (exercise intolerance) |
First Aid cross-reference: Glycogen storage diseases table (Biochemistry—Carbohydrate metabolism). Andersen is typically listed as Type IV: branching enzyme deficiency → hepatomegaly, cirrhosis, failure to thrive.
Definition (What It Is)
Andersen disease (GSD IV) is an autosomal recessive disorder caused by deficiency of the glycogen branching enzyme (amylo-α(1,4)→α(1,6)-transglucosidase), encoded by GBE1.
What the branching enzyme normally does
- Adds α(1,6) branch points to a growing glycogen chain.
- Creates a highly branched, compact, soluble glycogen particle.
- Increases the number of non-reducing ends, enabling faster glycogen synthesis and breakdown.
Pathophysiology (Why It Causes Cirrhosis)
Step-by-step mechanism
- Branching enzyme deficiency → fewer α(1,6) branches.
- Glycogen becomes abnormal: long, poorly branched chains (“amylopectin-like”).
- Abnormal glycogen is less soluble and can precipitate in tissues.
- The liver (and sometimes muscle/heart) experiences cell stress and injury.
- Chronic hepatocellular injury → inflammation → fibrosis → cirrhosis → portal HTN/liver failure.
The “HY contrast” with other GSDs
- Andersen: the hallmark is progressive cirrhosis due to toxic glycogen structure.
- Many other GSDs are more about energy failure/hypoglycemia or exercise intolerance rather than early cirrhosis.
Clinical Presentation (How It Shows Up in Vignettes)
Classic presentation (most testable)
- Infant with:
- Failure to thrive
- Hepatomegaly
- Progressive liver dysfunction
- Cirrhosis (often by early childhood)
- Can progress to:
- Portal hypertension (splenomegaly, ascites, varices)
- Jaundice, coagulopathy (easy bruising)
- Liver failure
Labs you might see
- Elevated AST/ALT
- Hyperbilirubinemia and signs of cholestasis in advanced disease
- Coagulopathy: elevated PT/INR due to reduced hepatic synthesis
- Hypoglycemia is not the main defining feature (unlike Von Gierke), though poor intake and liver dysfunction can contribute later.
Variants (less common but Step-worthy)
GBE1 mutations can produce a spectrum:
- Hepatic form (classic): progressive cirrhosis
- Neuromuscular forms (rare): hypotonia, cardiomyopathy or muscle involvement
Diagnosis (What Confirms It)
High-yield approach
- Clinical suspicion: infant/child with hepatomegaly + progressive cirrhosis
- Definitive testing:
- Enzyme assay showing low branching enzyme activity or
- Genetic testing: GBE1 mutation
- Liver biopsy (historically used; now often replaced by genetics):
- Abnormal glycogen with fewer branches
- May show fibrosis/cirrhosis
Differentials to keep straight
| Disease | How it can look similar | Key distinguisher |
|---|---|---|
| Von Gierke (I) | Hepatomegaly in infancy | Severe fasting hypoglycemia, lactic acidosis, hyperuricemia, hyperlipidemia |
| Pompe (II) | Cardiomyopathy in infant | Lysosomal glycogen accumulation, hypotonia, cardiomegaly |
| Hereditary fructose intolerance | FTT, vomiting, liver dysfunction | Triggered by фруктose/sucrose; hypoglycemia after fruit/juice |
| Tyrosinemia type I | Liver failure in infancy | Succinylacetone, cabbage-like odor, renal Fanconi |
Treatment (What You Do)
Mainstay (most important concept)
- Liver transplantation is the definitive treatment for the classic progressive hepatic form.
Supportive care
- Nutritional support to optimize growth
- Management of cirrhosis complications:
- Fat-soluble vitamin supplementation (A, D, E, K) if cholestatic
- Ascites management (salt restriction/diuretics)
- Variceal surveillance in advanced disease
- In neuromuscular variants, care is supportive and specialized.
Step framing: Unlike several GSDs where dietary strategies are central (e.g., cornstarch for Von Gierke), Andersen’s high-yield “endpoint” is progressive cirrhosis → transplant.
High-Yield Associations & Memory Hooks
The one-liner you should be able to recite
Andersen (GSD IV): branching enzyme deficiency → abnormal glycogen (fewer branches, amylopectin-like) → hepatomegaly + progressive cirrhosis + failure to thrive → liver transplant.
What Step questions love to test
- Enzyme name and bond type: branching enzyme makes α(1,6) linkages.
- Clinical “tell”: cirrhosis in a young child with glycogen storage disease.
- Pattern recognition: liver disease is progressive (not just hepatomegaly).
- Genetics: autosomal recessive.
Rapid comparison: branching vs debranching
| Enzyme | Disease | Linkage | Typical Step clue |
|---|---|---|---|
| Branching enzyme | Andersen (IV) | makes α(1,6) branches | Progressive cirrhosis |
| Debranching enzyme | Cori (III) | removes α(1,6) branches | Hepatomegaly + milder hypoglycemia, muscle weakness |
First Aid Cross-References (How to Find It Fast)
Look under:
- Biochemistry → Carbohydrate metabolism → Glycogen storage diseases
- Type IV (Andersen): branching enzyme deficiency → hepatomegaly, cirrhosis, failure to thrive
- Also useful adjacent pages:
- Glycogen structure & enzymes (branching/debranching, α(1,4) and α(1,6) linkages)
(Page numbers vary by edition—use the GSD table and the glycogen metabolism diagram.)
Common Exam Pitfalls (Avoid These)
- Mixing up Pompe and Andersen: Pompe is lysosomal acid α-glucosidase → cardiomegaly + hypotonia, not primary cirrhosis.
- Assuming all hepatic GSDs cause severe hypoglycemia: Andersen’s defining feature is cirrhosis from toxic glycogen, not dramatic fasting hypoglycemia.
- Confusing branching vs debranching:
- Andersen = can’t branch → long, insoluble chains
- Cori = can’t debranch → “limit dextrin,” usually milder liver disease
Mini-Vignette (Test-Style Pattern)
A 10-month-old has poor weight gain and progressive abdominal distension. Exam shows hepatosplenomegaly. Labs show elevated transaminases and evidence of developing portal hypertension. Liver biopsy shows cirrhosis and abnormal glycogen with decreased branching.
Answer: Branching enzyme deficiency (GSD IV, Andersen) → consider liver transplant.